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cX@&W. This study examined tbe bypotbesis that adenosine 
could pnwke a wovagal response in susceptible patients. Mecb- 
anisms oftbe vasovagal response were futiber explored by study- 




17 years). Adenoslne bolss injectiis of 6 mg and 12 mg were 
squatMy admimd to patients in the oprigbt position. Tbe 
same protod was implemented in 14 normal control subjects (7 
menand7women,me43n[*SD]age38~lOyears). 
Rem&s. Transient byperkasion or taciiyeardia was observed in 
57 (67%) aed 28 (24%) paths after administration of 6 mg and 
The triggering mechanisms of common fainting, the prototype 
of vasovagal syncope, have been extensively investigated over 
the past 40 years (1-13). The apparent paradoxic responses 
(i.e., increased vagal and decreased sympathetic tone) imme- 
diately before syncope can now be explained by the complex 
interactions that take place between the autonomic nervous 
system and the cardiovascular system. Situations that provoke 
fainting are usually first accompanied by hemodynamic 
changes associated with increased sympathetic netvous system 
activity. Subsequently, the decrease in heart rate typical of 
vagal activation and the sudden decrease in systemic vascular 
resistance, at least in part due to sympathetic withdrawal, 
supervene. The net result is a loss of consciousness due to 
impairment in the capacity to maintain adequate cerebral 
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12 mg of adenosine, respectively, during the immediite phase 
(tirst 15 s), suggesting direct sympathetic activation. Hypotension 
and reflex tacbyeardh were observed in all patients during the 
delayed plmse (l5 to 60 s after adenosine i&ction), sugg&ing 
baroreceptor unloading. A vasovagal response WIS indnced is 22 
(26%) and 29 (34%) patients &er adenosine administration and 
during tilt-table testing. Inducibility of a vasovagal response by 
tbese two methods was comparable (p = 0.12). Of the control 
wbjeets, one (7%) bad a vasovagal response after adenoshe 
administration and one (7%) bad a positive response dnring 
tilt-table testing 
Concfns~. These observations support the idea that &no- 
sine is an endogenoos moduhw of the cardiac excitatory a&rent 
nerves. Sympathetic activation by adenosine can be dii (i.e., 
cardiac excitatory afferent nerves) and indii (ii., vasodilation 
and reflex sympathetic activation). Adenosine could be an impor- 
tant modulatcr in triggering u vasovapl response in susceptible 
patients during examination for syncope. 
(JAm Ckdl comlio 19%:28:146-54) 
perfusion. Although the observation of preexisting sympathetic 
activation can frequently be attributed to a centrai origin (e.g., 
anxiety, fear, emotional distress, and anticipation), decreased 
ventricular filling and transient hypotension in an upright 
position are also important factors that contribute to fainting 
(14-16). Presumably, cardiac excitatory sensory endings con- 
nected to sympathetic afferent nerves are activated in the 
upright position, causing increases in sympathetic efferent 
activity (17,18). 
Adenosice is an endogeoous nucleosi& that mediates 
important physiologic responses in multiple organ systems. In 
addition to its negative chronotropic and dromotropic effects 
(19,29), adenosine also promotes vasodilation, decreases cen- 
tral and peripheral sympathetic efferent nerve activity (21.-24) 
and inhibits renin release (25). In contrast to these inhibitory 
actions of adenosine, some studies have demonstrated that 
adenosine directly activates cardiac excitatotj aperent fibers, 
resuhing in increases in heart rate and systolic blood pressure 
in conscious subjects (26-28). Although these observations 
strongly sugest that adenosine can mediate sympathetic aeti- 
-Ition, adenosine’s relative contriiution as a trigger in vaso- 
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vagal syncope is unknown. Because vasodilation and sympa- 
thetic activation are factors predisposing to a vasovagal 
response, we propose that adenosine can induce a vasovagal 
reaction in susceptible patients and that adenosine might be an 
important endogenous modulator in the complex scheme of a 
vasovagal reaction. Inducibility of a vasovagal response by 
adenosine was compared with the head-up tilt-table test with 
or without isoproterenol test. 
Methods 
Patient &ction. Between March 1992 and February 1993, 
85 patients underwent a head-up tilt-table test with or without 
isoproterenol and an adenosine challenge test. Each patient 
had at least one episode of syncope or recurrent presyncope, 
:hc cause of which remained uncertain despite comprehensive 
medical and neurologic evaluation when appropriate. Patients 
with orthostatic hypotension, significant anemia (hemoglobin 
< 11 gldl) and endocrinologic abnormalities such as diabetes, 
hypoglycemia and thyroid dysfunction were excluded from the 
study. Patients with an abnormal finding during electrophysi- 
ologic testing (29) (defined as carotid sinus hypersensitivity, 
sinus node dysfunction, atrioventricular conduction system 
disease or sustained ventricular arrhythmias correlated with 
the patient’s clinical symptoms) were also excluded from the 
study. Fourteen normal control subjects who never had syn- 
cope or presyncope were also examined. 
Study protocol Electrocardiographic leads I, II, III, aVF, 
V, and V, were continuously monitored. Continuous arterial 
pressure was monitored by an intraarterial catheter. Simulta- 
neous recoramgs were obtained from a paper recorder (Gould, 
ES2000 KB, paper speed 50 or 100 mm/s), a video recorder 
(TEAC, XR-510) and a computer (EP Lab). 
All studies were performed with the patient in the fasting 
state, after standard atrial and ventricular programmed stim- 
ulation as well as carotid sinus massage. After baseline mea- 
surements of heart rate and blood press~*~~, each patient was 
tilted to the upright position at a 65” angle on a tilt table with 
a footboard made for standing. The baseline head-up tilt test 
was 15 min in duration. At the conclusion of the baseline tilt. 
adenosine was administered in the upright position. If a 
vasovagal response was induced during the baseline tilt, the 
patient was immediately returned to the supine position. After 
a complete recovery, the patient was tilted up again before the 
administration of adenosine. 
Adenosine bolus injections of 6 mg and 12 mg were 
administered through the distal cephalii vein at the site nearest 
the peripheral access, with a minii amount of Teflon tubii 
Immediately after each injection, the intravenous catheter was 
‘ttushedwithlOmlofisotonic~.Thetestbeganwiththe 
first dose of adenosine (6 rap). Heart rate and blood pr.zzre 
were monitored continuously for a minimum of 3 min after 
adenoaine it+&ion. If a w reaction was not indua$ 
the same prncedure was repeated with 12 mg of a&nc&e. If 
symptomsofpnsynoope orsyncope~~thepatient~ 
~~~~~~~~~~~~ 
complications, and resumption of the supine position alone 
was sufficient to reverse bradycardia and hypotension in sos- 
ceptible subjects. 
At the conclusion of the adenosine challenge test, a 
head-up tilt test with isoproterenol was conducted in patients 
who had a negative response to baseline tilt. Isoproterenol was 
infused incrementally at 1, 3 and 5 @min. A given dose of 
isoproterenol war infused continuously for 5 min in both the 
supine and upright positions. The test was completed when 
either 80% of the predicted peak heart rate ([220 - age] x 
0.8) or the maximal dose (5 &min) of isoproterenol was 
achieved. 
BefinItIons. For each adenosine injection. the time se- 
quence of hemodynamic responses was divided into four 
phases. The baseline hemodynamic data were defined as the 
heart rate and blood pressure at the time of adenosine 
injection (time 0). The irme~fephe was from 1 to 15 s after 
adenosine injection. The delayed phase was from 15 to 60 s 
after adenosine injection. The pdmtgedphe was from 60 to 
180 s after adenosine injection. 
Syncope was delined as a transient loss of consciousness. 
Premope was defined a$ premonitory signs and symptoms of 
imminent syncope (e.g., severe lightheadedness, transient 
hearing loss, graying of vision. or severe weakness). 
A posizive tesz was defined by a provocation of a vasovagal 
reaction during the prolonged phase after adenosine adminis- 
tration or during the tilt-table test. A vasovagal respzw was 
defined by the development of syncope or presyncope in 
association with relative bradycardia (at least 20% decrease i? 
heart rate from the delayed phase) or hypotension (minimal 
decrease in systolic blood pressure of 30 mm Hg), 3r both. 
StatistIcaI an+&. Group comparisons of baseline char- 
acteristics between those subjects with and without a vasovagal 
response were calculated using the Student t test or Pearson’s 
chi-square test for proportions. For each patient, maxima 
changes from baseline were determined for heart rate and 
wtolii arterial pressure in response to adenosine during each 
of three ph -mediate, delayed and prolonged. Ibe 
resulting data from baseline and tbe three response phases 
were submitted to two-way analysis of variance (ANOVA) for 
repeated measures. Hypotheses of interest were overall dither- 
ences between those subjects with and without a vasovagal 
response and group&y-time interactions representing diier- 
ential changes from baseliie according to vasovagal response. 
These overall hypotheses were tested using the ANOVA 
overall F test for group differences on 1 and 83 degrees of 
freedom and the ANOVA F test for group-by-time interac- 
tions on 3 and 81 d@rees of ~KXX@. For descriptive pur-’ 
pasw, and because of the large d&fence in bemodynamic 
responses between the tw groups during the prolonged phase 
ad its possible impact on ANOVA, the data were also 
eaafyred separatety at each time point us& the Wiion 
d-wmtest.‘lhedatawerepbttalbytimeasmean +- 1 SD. 
Apvalue=O.O5wa.samsideredsi@i6W. 
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Table 1. Transient Snnptoms After Adenosine Administration Table 2. Character&tin of Adenosine Response 
DiaphMesis 52 (61) 
Lighlheadedness 50(59) 
shortness of brearh 23 (27) 
NZW&3 28 (33) 
Headache 12 (14) 
Vomiting j(6) 
*ty 3 (4) 
Blurred vision 2 (2) 
Pts = patitm. 
Results 
Mnngraphii. The mean (*SD) 2ge of the 85 patients 
was 61 2 17 years (range 16 to 91). There were 34 women and 
51 men. Of the 85 patients, 18 (21%) had a history of 
presyncope and 67 (79%) had syncope. Of the 67 patients with 
syncope, 36 (54%) had recurrent syncope. Heart disease was 
present in 27 (32%) patients. The left ventricular function was 
documented in 49 (58%) patients. ‘fhe mean left ventricular 
ejection fraction was 059 -C 0.09. Only live patients had an 
ejection fraction ~0.50. Bundle branch block morphology or 
intraventricular conduction delay was observed on the surface 
eleetrocardiiram in 11 patients. A 24-h Holter monitor 
measurement was taken in 31 patients. Asymptomatic brady- 
cardia, supraventricular tachycardia and nonsustained ventric- 
ular tachycardia were observed in 13 patients, but these 
findings were thought not to be the cause of syncope or 
presyncope. During ele-ctrophysiologic testing, mild sinus node 
dysfimction (corrected sinus node recovery time between 525 
and 600 ms) or atrioventricular conduction system disease 
(His-ventricular interval between 55 and 65 ms) was observed 
in seven patients. None of the patients had inducible sustained 
ventricular arrhythmias. 
Symptoms associated with adennsine. Symptoms reported 
by patients after adenosine injection are summarized in Table 
1. Sensations of diaphoresis and lightheaoedness were the 
most frequently encountered symptoms. The longest pauses 
were 5 s and 11 s after 6 mg and 12 mg of adenosine, 
respectively. None of the patien experienced syncope as a 
result of adenosine-induced bradycardia or pauses during the 
immediate phase. All symptoms listed in Table 1 were tran- 
sient. 
Wn@namk responses to adem&e. Responses to aden- 
osine were divided into four phases on the basis of the time 
seqmce, as previously defined. Responses were categorized 
into four types on the basis of the hemodynamic changes 
during each phase after adenosine adminiitration (Table 2). 
Tp I respunx. This was delined as transient tachycardia 
or hypertension, or both, observed during the immediate phase 
after adenmine injection (Grst 15 s). Hemodynamic changes 
typicalofatypeIrespWeareshowninF&ure1.Duringtbe 
immediate phase after &no&e @ection, tmnsient hyperten- 
sion and taem were frequently observed (Fii IA). 
These respmws were followed by persistent tachycardia and 
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RapWM Immediate Delayed Prolonged 
Type (I-15 5) (16~60 5) (61-180 6) 
I 1 HR, 7 BP, or bath THR, LBP Return (0 baseliw 
II IHR f HR. 1 BP Return to baseline 
111 1 HR, r BP, or both tHR, LiJP 1 BP (syncope or 
Presyn@pe) 
IV 1 HR tHR, IBP lBP(vmpeor 
P~esyncope) 
BP = blood pressure: HR = heart rate: t = increase; 5 = decrease. 
gradual hypotension extending into the delayed phase. The 
peak hypotensive effect usually occurred -30 to 45 s after 
adenosine injection. From this point on, blood pressure and 
heart rate gradually returned to the baseline level. By the time 
of the prolonged phase (after 60 s), patients with this type ef 
response were free of symptoms and hemodynamic data 
returned to baseline levels. In a subgroup of patients, hyper- 
tension was observed in the absence of tachycardia during the 
immediate phase after adenosine administration (Fig. 1B). 
Type I1 response. This was defined as transient bradycardia 
(~20% decrease in heart rate from baseline) observed after 
adenosine injection. Blood pressure and heart rate responses 
typical of a type II response are shown in Figure 2A. Shortly 
after adenosine administration, significant bradycardia was 
observed during the immediate phase. This was usually asso- 
ciated with a transient decrease in blood pressure primarily 
caused by bradycardia. After the pause and hypotension, 
tachycardia and relative hypotension continued into the de- 
layed phase. These changes subsided, and hemodynamic data 
returned to baseline levels during the prolonged phase. An 
increase in blood pressure was frequently observed before the 
adenosine-induced bradycardia and bradycardia-related hype- 
tension. In some patients, a divergent effect on the sinoatrial 
node and the atrioventricular node was observed. Sinus tachy- 
cardia could occur in the presence of significant atrioventric- 
ular block (Fig. 2B). 
Type III response. The immediate and delayed hrlrlody- 
namic changes of a type III response were similar to those of 
a type I response; however, hypotension persisted and pro- 
gressed into the prolonged phase after adenosine administra- 
tion (Fig. 3). Patients experienced lightheadedness, diapbore- 
sis and presync+l symptoms typicsir of a vasovagal response. 
These symptoms were associated with a further decline in 
blood pressure and paradoxic bradycardii 
Typ- :Y respme. The hemodynamic changes of a type IV 
respnse are shown in Figure 4. Immediate and delayed phase 
c+nges of a type IV response were similar to those of a type 
II response; however, after the delayed phase of hypotensiou 
and ta&ycardia, the hypotension progressed into the prc- 
response was ‘“d”d. 
respnnse. Systobc blood 
pressureandheartrateinre+nseto6mgofadenosine.are 
shown in Fii 5. ANOVA for systolii blood pressure at 6 mg 
JACC Vol. ‘ht. No. I 
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F&gnre 1. Type I adenosine response. The top 
tracing is a single lead from a surface electro- 
cardiogram (ECG). The bottom tracing is the 
blood pressure (BP) from a continuous intraar- 
terial recordiig. Corresponding cardiac cvcle 
lengths (CL.) and blood pressures are ihus- 
trated. A, Adenosine (6 mg) wa5 administered 
at the onset of this recording. During the 
immediate phase after adeaosine injection (first 
15 s), transient hypertension and tachycardia 
were observed. These responses were followed 
by persistent tachycardii and gradual hypotec- 
sion extending into the delayed phase (16 to 
60 s). The ; -ak hypotensive effect occurred 
-30 to 45 s after adenosine injection. From thii 
point on, blood pressure and heart rate gradu- 
ally returned to baseline levels. During the 
prolonged phase (aider 60 s), hemodynamii 
vahtes returned to baseline. B, After injection 
of 12 mg of adenosine, hypertension occurred 
in the absence of tachycardia during the imme- 
diate phase. This was followed by hypotension 
and tach~cardia in the delayed phase. 
SHEN ET AL. 
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indicated a sign&ant overall group difference between re- 
sponders and nonresponders (p = 0.0004), as weU as a 
si@icant group-by-time interaction @ = 0.0001). ANOVA 
for heart rate indicated a significant overall gtottp difference 
only (p = 0.0174). Comparing the groups at each time point 
using the Wilcoxon rank-sum test showed a signif&tt diier- 
ence in mean systolic blood pressure and heart rate at the 
delayed and prolonged phases. Group comparison of the mean 
change from baseline indicated a significant dilference in 
systolic blood pressure response in the delayed and prolonged 
phases and a signihcant difference in heart rate response in the 
prolonged phase only. 
SystoIii blood pressure and heart rate in response to 12 mg 
of adenosine are shown in Figure 6. ANOVA for systolii blood 
pressure at 12 mg of adenesine indicated a signihcant overall 
group ditference (p = O.OtXl) and 3 group-by-time interaction 
@ = O.OtXll). For heart rfe, ANOVA indicated a marginally 
significant group diflerence (p = 0.043g). Compming the two 
groups at each phase of the study using the Wilcox00 rank-sum 
test showed a signihcant difference in the mean systolic bkrod 
pressure at the delayed and probnged phases as well s in the 
meanlmrtrateattbeproloage4Ipbase.tZmpara~results 
wereessentiaUythesamewbenexpmsedasdmgefmm 
baseliue. . . 
c%mekMm of patients with and witbut adenosioe- 
induced vasovagal response are summarized in Table 3. There 
were more women in the group with vasovagal responses (p = 
O.CHl9). Other variables, such as age, frequency of syncope 
before adenosine testing, presence of undetiying heart disease 
and left ventricular ejectiin fraction, were not signiitIy 
different in these two groups. 
Dose-r&ted responses to adenosbte. Adenosine-induced 
bradycardia (type II and rV responses) was more frequent 
after 12 mg than 6 mg of adenosine. A total of 22 patients had 
adenosine-induced vasovagaI msponse (types III and IV). The 
vasovagaI response was induced in 6 patients after 6 mg of 
adenosine and in 16 additional patients after 12 mg of adew- 
sine. 
izotalparlsonoftlfe2deltwlttetw-tobIete2twitbtbe 
hend-np tIM test. A total of 33 patients responded to either 
adenosine or the head-up tilt-table test wrth or without isopro- 
terenol. Of the 33 patients, 18 responded to both adenosine 
aud the bead-up tilt-table test with or without isoprotere~ 11 
respooded otdy to the had-up tilt-tabk test with or without 
isoproterenoIand4respo&dtoadenosineonIy.Ifone 
assumes that the 33 patients represent an approsimationof the 
incidenceofMswagalsyncopeinthispatientpopuIatimxthc 
apparent sensitivity of- response huh&ion is 67% (22 
of33)for~~tilt-tabletestand~%(29of33)for 
the head-up tilt-tabk test with or withont koproterenol. The 
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Figure 2. Type II adenosine response. A, Recording tech- 
niaues are similar to those in Fiaure 1. A uause of 8.4 s 
o&red du;‘ng the immediate phase after injection of 
12 mg of adenosine. Transient hypertension preceded the 
pause. Hypotension and tachycardia occurred during the 







in the prolonged phase. B, Differential chronotropic and 
dmmotmpic responses to adenosine are shown. In the 
presence of atrioventricular block, paradoxic sinus tachy- 
cardia was observed immediately after adenosine injec- 
tion. Divergent RR and PP intervals are shown. Top and 
bottom electrocardiogram (ECG) and blood pressure 
(BP) tracings are continuous. CL = cycle length. 
difference between the positive outcomes induced by the two 
methods was not significantly different (p = 0.12). 
subject (7%) had a vasovagal response during the tilt-table test 
with isoproterenol at 5 Clg/min. 
Response ut’ normal subjects. The mean age of the 14 
control subjects was 38 + 10 years (range 19 to 62). One 
female subject (7%) had a vasovagal response induced after Discussion 
12 mg of adenosine. A type I response was obsewed in nine 
(64%) and three (21%) subjects after 6 and 12 mg of adeno- 
Adenosine was used to investigate mechanisms of vasovagal 
sine, twpcctivc.Iy. A type Ii response was observed in the 
syncope. Adenosine could provoke a classic vasovagal response 
remaining subjects tier each dose of adenosine. One male 
in susceptiile patients in the upright posit&m. The vasovagal 
response could be triggered by a direct adenosi&.nduced 
JACC Vol. 28, No. I 
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P&are 3. Type III adenosine response. The top tracings 
were recorded at a paper speed live times slower than the 
bottom tracin@. The bottom remrdings correspond to the 
sequence of events that occurred after adenosine adminis- 
tration, as indicated by the letters A through D. Baseline 
hemodynamic values correspond to point A. Transient 
hypertension and tacbycardia oaurred S,r’,,g Ike immedi- 
ate phase after adenosine injectioo (6). This was followed 
by hypoteasion and tacbycardia during the delayed phase 
(C). Hypotension persisted ink the prolonged phase in 
association with relative bradyctidia. This patient experi- 
enced sync~pe at point D. Synptoms subsided after the 
patient was returned to the q&e position. BP = blood 





sympathetic activation and vasodilation. The adenosine- 
induced sympathetic activation was demonstrated by transient 
hypertension and tachycardia shortly after adenosine adminis- 
tration. Inducibility of a vasovagal response by adenosine was 
alsO compared with the head-up tilt-table test with or without 
isoproterenol. Tbe positive yields of these two provocative 
tests in inducing a vasovagal response were comparable (p = 
0.12). 
Adenosine-mediated car&c excitation. The excitatory ef- 
fects of adenosine in tbe cardiovascular system were recently 
reported. Increased heart rate and blood pressure were ob- 
setied after bolus injections of adenosine (27) and during 
constant infusion (26). Adenosine-mediated bemodynamic 
changes were thought to be caused by ac$vating tbe card& 
excitatory alferent nerves. The transient incmse in heart rate 
and blood pressure observed during tbe immediate phase in 
patients with type I and III responses after adenosine injection 
in our study is consistent witb tbe concept that adenosine 
activates the sympathetic tierent fibe.ts (Fig. 1 and 3). Tacby- 
cardia occurring at the time of bypertenskn essentially ex- 
cludes UK pnddity of arterial banweceptor m&&g @e&x 
tZ#CbyCUdia)IstheUt.Ide~-dtUiilgtheilMledi- 
ate phase response. The observation of sympathetic activation 
was frequently masked by the direct negative dromotropic and 
cbronotropic effects of adeno4ne. The observed heart rate 
during the immediate phase reflects a balance= between, 
a~enosine-mediated bradycardia and adenosine-induced sym- 
pathetic activation. This net balance is &own in Figure 2A; the 
adenosine-induced pause was preceded by an increase in blood 
pressure. Respomes of the sinoatrial node and tbe atrioven- 
tricular node could also be divergent, especially under the 
influence of sympathetic activation (Fig. 2B). Although siguif- 
icandy decreased heart rate occurred as a result of tbe negative 
dromotropic e&ct of adenosine on the atrioventrkular node, 
sinus tacbycardia was observed at the same t@e. ‘Ibis para 
doxiceffectco&ibeexplainedbytbesmaiierdirectnegative 
chri~notropic effect of adenosine on tbe sinoatkai node and tbe 
cotitrmt sympathetic activation mediated by’adenosine. 
The consistent -tension and tacbycardia observed dur- 
ing the delayed phase can be explained by the direct vasodik- 
tory effect of adenosine. As vasodiiation occurred, arterial 
baroreceptor unloading further increased tbe sympathetic traf- 
tic and led to reflex ta@ca&a. 
Rdeef~is - hdsympa- 
thetie aftivity immediately belore a vasovagal respame has 
beendiiobservedinanimakandb~nsInanexperi- 
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Pii 4. Type IV adenosine response. Recording techniques are 
similar to those in Piire 1. Baseline hemodynamic values correspond 
to point k A pause was observed during the immediate phase (5). 
After the delayed phase, persistent hypotension and bradycardia 
occurred during the prolonged phase (C). These hemodynamic re- 
sponses were associated with classic vasovagal symptoms. The patient 
experienced syncope. Symptoms subsided after the patient was re- 
turned to the supine position, corresponding to D. BP = blood 
pressure; CL = cyck length; ECG = electrocardiogram. 
mental model (8), hypovolemia in an open-chest cat prepara- 
tion was ac.compauied by marked activation of ventricular 
mechanoreceptor activity immediately before reflex tachycar- 
dia. Peripheral autonomic nervous system activity during va- 
sovagal syncope was later documented (12) in humans by 
microelectrode recordings from peroneal nerve fascicles. In- 
creased sympathetic activity was noted initially, but with the 
onset of syncope, sympathetic outflow suddenly ceased. It is 
believed (30-32) that preload reduction that results in sympa- 
thetic activation, vigorous ventricular contraction and actival 
tion of endocardial mechanoreceptors leads to the inhibitory 
Bezold-J&h reflex, resuhing in vasovagal syncope. The 
mechanism underlying the interaction between preload reduc- 
don and sympathetic activation is unknown. Our results raise 
the possiiility that adenosine is an endogenous modulator of 
,the cardiac excitatory a&rent nerve system, and adenosine- 
mediated sympathetic activation might be an important trig- 
gering mechanism for a vasovagal response. The concomitant 
byperte.asive and tacbycardic responses immediately after 
JACC Vol. 28, No. 1 
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Pii 5. Hemodynamic response to 6 mg of adenosine. The x axis 
expresses the time sequence, as defined in the text, after adenosine 
injection. Heart rate and systolic blood pressure are expressed as 
mean 2 SD. *p < 0.05 and **p < 0.01 denote the difference between 
groups at each time point. #p < 0.05 and ##p < 0.01 denote the 
difference in change from baseline within a given group. bpm = beats 
per minute. 
adenosine administration strongly suggest that adenosine is 
involved in atTerent sympathetic chemoreceptor activation. 
This excitatory property of adenosine has been observed by 
other investigators (X,27,33-35). A direct central effect of 
adenosine is unlikely because studies in dogs have indicated 
that adenosine does not cross the blood-brain barrier (36). 
Although it is conceivable that carotid baroreceptom may be 
activated under the influence of hypertension, none of our 
patients had abnormalities associated with carotid sinus mas- 
sage. 
Although the myocardium is beheved to be the primary 
reflexogenic area that triggers vasovagal syncope, other mech- 
anisms are implicated, including the interaction between pe- 
ripheral afferent responses and the higher centers, such as the 
hypothalamus (17,37). Recent studies (37,38) of cardiac trans- 
plant recipients whose hearts were denervated described typi- 
cal vasovagal responses. The abrupt change of sympathetic 
tone was associated with hypotension and near syncope with- 
out bradycardia. This observation suggests that the activation 
of peripheral atferent impulses under conditions such as 
hypotension may also conmbute to this inhibitory reflex with- 
out ventricular activation. The adenosme-mediated hypoten- 
sion preceding the vasovagal response in susceptible patients 
also supports the importance of peripheral receptor activation 
in this complex scheme of vasovagal syncope. 
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Fi 6. Hemodynamic response to 12 mg of adenosine. The x ads 
exprcses the time sequence, as detined in the text, after adenosine 
injection. Heart rate and systolic bloou pressure are expressed as 
mean t- SD. “p < 0.01 denotes the difference between groups at each 
time point. ##p < 0.01 denotes tile difference in change from baseline 
within a given group. bpm = beats per minute. 
Although not examined in the present study, pharmacologic 
interventions also support the idea that adenosine may play an 
important role in triggering a vasovagal reaction. A recent 
study (39) found that theophylline, a nonspecific adenosine 
receptor blocker, could prevent vasovagal syncope. This report 
and our observations do not distinguish the relative contribu- 
tion of cardiac excitatory afferent activation from peripheral 
baroreceptor activation in triggering the vasovagal response. 
To assess the diierent effects of adenosine, specific adenosme 
antagonists may be of great importance. It has been observed 
(40,41) that A:- and As-receptors are preferentially distributed 
in the cardiac and vascular smooth muscle systems, respec- 
tively. Wective block of the different adenosine receptors will 
Tahie 3. Characteristics of Patients With or Without 
Adenosine-Induced Vasovagal Response 
Makffemnk 43Ro 8/14 0.009 
Age@) 59 2 18 64 2 17 0.16 
-asyocope 28 8 0.48 
Heartdisease 20 7 053 
E@ion fraaion 057 -c 0.14 0.61+ 0.05 0.08 
Datapveseotednremeanvahle~8Doraumtmrofpatieras. 
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be invaluable in the evaluation of mechanisms and in the 
implementation of therapies in patients with vasovagal syn- 
cope. The greater prevalence of women among the group of 
patients with adenosine-induced vasovagai response might 
suggest that triggering mechanisms may be different for males 
and females. 
The negative responses in’normal control subjects and the 
similar positive responses induced by the head-up tilt-table test 
with or without isoproterenoi also support the idea that 
adenosine-mediated reactions were the most likely mechanism 
for the patients’ symptoms, as opposed to nonspecific re- 
sponses to the drug. The ditferences between these two 
provocative tests are intriguing, but can be explained on the 
basis of the pharmacologic actions. Isoproterenol is an agonist 
to the beta-adrenergic efferent fibers. The sites of adenosine 
action are the cardiac sympathetic afferent fibers and the 
peripheral vasculature. It is not surprising that some differ- 
ences exist between these two tests. It also points out the 
complexity in the triggering mechanisms of vasovagal syncope. 
Clinicalimp~~saaedco~usions. The resuhsoftbis 
study have some important clinical implications. The diagnosis 
and treatment of vasovagal syncope are ditficult in some 
patients. Although the head-up tilt-table test with or without 
isoproterenol has been recognized as a useful test to provoke 
a vasovagal response, a standard protocol has not been estab- 
lished, in part owing to the prolonged duration of the head-up 
tilt and multiple dosing regimens of isoproterenol mfusion 
(42-44). Adenosine may provide a more elhcient alternative 
diagnostic method in thii patient population. Studies of its 
sensitivity, specificity, reproducibiity and cost-effectiveness are 
needed. 
Responses to the adenosine tilt-table test may also aid in 
therapeutic decisions. Current pharmacologic options for va- 
sovagal syncope include beta-adrenergic blocking agents, anti- 
cholmergic agents, theophylline and alpha agonists (43-51) 
Selection of a drug is largely empirical. Responses are usually 
unpredictable. Randomized studies of the responses to aden- 
osine and the head-up tilt test could help to achieve a more 
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